One study did not find significant differences in IL-23 levels in COVID-19 patients compared to healthy controls [64]; however, it also did not find significant differences in IL-17 levels, calling into question the statistical power of the study given the body of evidence outlined above in support of elevated levels of IL-17 during COVID-19 infection. The gene discussed is IL17A; the disease is COVID-19.